Vir Biotechnology, Inc. (VIR)
10.47
+0.06
(+0.58%)
USD |
NASDAQ |
Oct 15, 16:00
10.47
0.00 (0.00%)
After-Hours: 20:00
Vir Biotechnology Cash from Operations (TTM) : -202.51M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -202.51M |
| March 31, 2026 | -446.05M |
| December 31, 2025 | -391.78M |
| September 30, 2025 | -453.54M |
| June 30, 2025 | -457.45M |
| March 31, 2025 | -415.08M |
| December 31, 2024 | -446.35M |
| September 30, 2024 | -466.64M |
| June 30, 2024 | -450.99M |
| March 31, 2024 | -762.39M |
| December 31, 2023 | -778.78M |
| September 30, 2023 | -635.73M |
| Date | Value |
|---|---|
| June 30, 2023 | -362.00M |
| March 31, 2023 | 987.38M |
| December 31, 2022 | 1.663B |
| September 30, 2022 | 1.636B |
| June 30, 2022 | 1.412B |
| March 31, 2022 | 592.03M |
| December 31, 2021 | -47.59M |
| September 30, 2021 | -137.34M |
| June 30, 2021 | -81.36M |
| March 31, 2021 | -232.06M |
| December 31, 2020 | -190.94M |
| September 30, 2020 | -147.77M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Moderna, Inc. | -1.073B |
| Vaxcyte, Inc. | -881.23M |
| Caribou Biosciences, Inc. | -95.78M |
| Arrowhead Pharmaceuticals, Inc. | -59.06M |
| Oncolytics Biotech, Inc. | -26.52M |